Subject Matter of the Lobbying Activity
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Promote the development of a Pan Canadian health strategy, including the creation policies addressing biosimilars and the implementation of a national pharmacare program.
|
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
To contribute to British Columbia’s economic prosperity by recommending policies that will attract increased investment. Activities could include providing recommendations on tax policies, research programs and policies, as well as policies and programs regarding innovation. Focus of lobbying efforts is on representations relating to the conditions under which biosimilar drugs are marketed and reimbursed in British Columbia, including under the BC PharmaCare programs. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current women’s health programs, the integration of biosimilar drugs into the BC PharmaCare programs.
|
- Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly
- Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|